Lilly Received Marketing Authorization For Tirzepatide In India
New Delhi: The popular weight loss and diabetes drug Tirzepatide — marketed as Mounjaro and Zepbound in the US — is likely to hit the markets in India though there has…
Drugmakers’ Appeal To End Zantac Cancer Lawsuits Rebuffed By Judge
London: A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac causes cancer to go…
Mumbai: Drug Lord Reveals A Web Of Ops
Mumbai: Interrogation of drug lord Aliasgar Shirazi has revealed a web of operations spanning the courier and pharmaceutical sectors that served his illegal trafficking of psychotropic medicines to the United States…
Madras HC Sets Aside Ban On Online Sale Of Medicines
Chennai: In a relief for online pharmacies, including Tata 1mg, Practo, PharmEasy and NetMeds, the Madras High Court has reportedly set aside an earlier order by a single judge bench…
GB Nagar: Himachal Drug Makers Booked For Sub-Standard Medicines
NOIDA: The drugs control department of Gautam Budh Nagar district has registered a case against two Himachal Pradesh-located manufacturers/producers for allegedly making and selling “unfit” antibiotic medicines, officials aware of…
Glenmark Recalls 114 Batches Of Low Potassium Drug In The US Over Potentially Deadly Hyperkalemia Risk
MAHWAH, N.J. : While patients with low potassium often need medication to boost levels of the electrolyte in the body, too much of a good thing can cause serious health concerns.…
Maharashtra Drug Inspector Arrested For Taking Rs 1 Lakh Bribe In Palghar
Palghar: Maharashtra’s Palghar district witnessed a dramatic turn of events on Wednesday as the Anti-Corruption Bureau (ACB) arrested drug inspector Arti Shirish Kambli and Krishnakumar Asaram Tiwari for allegedly demanding…
DCA Seizes Overpriced, Misleading Claim Medicine
Hyderabad: Officials from the Telangana Drugs Control Administration (DCA) in separate raids in Sangareddy and Suryapet districts seized overpriced drugs and also medicines with misleading advertisements. During a special drive, DCA…
DoP Further Expands List Of Special Invitees Into Committee Constituted To Reform Pricing Framework
New Delhi: The Department of Pharmaceuticals (DoP) has once again expanded the list of special invitees for its Committee for reforms in the pricing framework for drugs and medical devices, formed…
India Key Market For APIs, But Patients Forced To Cough Up Crores To Buy Orphan Drugs
HYDERABAD: Though India manufactures most of the key active pharmaceutical ingredients (APIs) for over 400 FDA-approved orphan drugs for rare diseases, patients back home are forced to cough up crores to…
